OLMA News and Press, Olema Pharmaceuticals Inc. From 11/23/20

SAN FRANCISCO, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, to...

Last week brought us six new IPOs, as well as 15 SPACs which raised $2.5 billion. Olema Pharmaceuticals (NASDAQ: OLMA), the breast cancer biotech company led the way as the week’s top performer while its stock skyrocketed 157% on its first day. Olema Pharmaceuticals was the only one ...

In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals, which soared 158% on its first day. New filings continued to pour in, priming the IPO pipeline for an active end to 2020. 10 IPOs a...

Sotera Health, Maravai Life Sciences, and Olema Pharmaceuticals (NASDAQ:OLMA) are all filing IPOs as "emerging growth companies" as defined by the 2012 Jumpstart Our Business Startups Act, which gives them extra time to comply with the accounting standards that are expected of public co...